Likewise, synthetic GLP-1 receptor agonists are used successfully in the treatment of type-2 diabetes mellitus and to reduce overweight in obesity (for recent reviews, see Nauck and Meier [5] and Hussein et al. [6]). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.